Mannkind Corporation (MNKD)
Last updated: 2026-10-20 23:53:00. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Summary
Mannkind Corporation (MNKD) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $3.10, with a market capitalization of $977.50M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.23 to $6.51. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$977.50M | |
$3.11 | |
$121.55 | |
$0.67 | |
$3.09 | |
1.81M | |
4.53M | |
-- | |
$6.51 | |
$2.23 | |
-- | |
-- |
Mannkind Corporation (MNKD) After-Hours Stock Price
Mannkind Corporation (MNKD) is trading at $3.15 in after-hours trading as of 2026-10-20 23:34:00, up 2.07% ($0.06) from the regular-session close of $3.09.
After-hours trading shows how investors are pricing MNKD after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
Mannkind Corporation (MNKD) 7-Day Stock Price Change
Over the past seven days, Mannkind Corporation (MNKD) moved from $3.29 to $3.10, representing a decline of 5.93% ($0.19).
The stock traded between $2.90 and $3.41 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.
The average daily volume was 4.24 million shares, down versus the previous seven-day period, indicating lower trading activity.
MNKD 52-Week Price Position
Position in Range: 20.2%
MNKD is currently trading at $3.10, placing it 20.2% of the way from its 52-week low of $2.23 to its 52-week high of $6.51. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Mannkind Corporation (MNKD)?
MannKind Corp is a biopharmaceutical company dedicated to transforming chronic disease care through patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, it develops and commercializes treatments that address unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease.
Mannkind Corporation Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 592 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Mannkind Corporation (MNKD) Stock on MEXC
Eligible investors can buy real shares of Mannkind Corporation (MNKD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Mannkind Corporation (MNKD) stock price today?
2.Is MNKD stock going up or down today?
3.What is MNKD pre-market price?
4.What is MNKD after-hours price?
5.Is MNKD stock trading now?
6.Where does MNKD sit relative to its 52-week high and low?
7.What sector is Mannkind Corporation in?
8.What is Mannkind Corporation's market capitalization and where is it listed?
9.How is MNKD valued in terms of P/E ratio and EPS?
10.Does Mannkind Corporation pay a dividend?
Explore More US Stocks
Search Stocks
MNKD Stock Calculator
Estimate the value between MNKD shares and USD.
MNKD Shares to USD
1.00 MNKD shares = 3.095 USD
Calculations are estimates based on the latest available price and are for reference only.


